{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:53:19Z","timestamp":1774885999649,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ajo.2021.09.008","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:21:40Z","timestamp":1632097300000},"page":"172-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effectiveness of Difluprednate for the Treatment of Anterior Scleritis"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1053-8651","authenticated-orcid":false,"given":"Paulina","family":"Liberman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryn M.","family":"Burkholder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan K.","family":"Berkenstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2021.09.008_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preteyeres.2013.02.004","article-title":"Scleritis: immunopathogenesis and molecular basis for therapy","volume":"35","author":"Wakefield","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2021.09.008_bib0002","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0454","article-title":"Therapy insight: scleritis and its relationship to systemic autoimmune disease","volume":"3","author":"Smith","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.ajo.2021.09.008_bib0003","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.09.008_bib0004","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0161-6420(93)31473-9","article-title":"An analysis of therapeutic decision for scleritis","volume":"100","author":"de la Maza","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.09.008_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/09273948.2015.1032308","article-title":"Flurbiprofen\u00a0: a non-selective cyclooxygenase (COX) inhibitor for treatment of non-infectious, non-necrotising anterior scleritis","volume":"24","author":"Agrawal","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2021.09.008_bib0006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","article-title":"Immunosuppression for the Uveitides","volume":"125","author":"Jabs","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.09.008_bib0007","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","article-title":"Scleritis and peripheral ulcerative keratitis","volume":"33","author":"Galor","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ajo.2021.09.008_bib0008","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1167\/iovs.13-12660","article-title":"Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study","volume":"55","author":"Sheppard","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.09.008_bib0009","unstructured":"US Food and Drug Administration. Drug approval package: Durezol (Difluprednate) NDA #022212. Accessed July 24, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/022212s000TOC.cfm"},{"key":"10.1016\/j.ajo.2021.09.008_bib0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.survophthal.2016.06.002","article-title":"Treatment and management of scleral disorders","volume":"61","author":"Daniel Diaz","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2021.09.008_bib0011","first-page":"217","article-title":"Use of topical steroid therapy in the management of non-necrotizing anterior scleritis","volume":"34","author":"McMullen","year":"1999","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.09.008_bib0012","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0161-6420(80)35177-4","article-title":"The diagnosis and management of scleritis","volume":"87","author":"Watson","year":"1980","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2021.09.008_bib0013","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.ophtha.2005.05.008","article-title":"Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis","volume":"112","author":"Albini","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.09.008_bib0014","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajo.2011.10.008","article-title":"Efficacy and potential complications of difluprednate use for pediatric uveitis","volume":"153","author":"Slabaugh","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.09.008_bib0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/archophthalmol.2011.82","article-title":"Elevation of intraocular pressure in patients with uveitis treated with topical difluprednate","volume":"129","author":"Birnbaum","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2021.09.008_bib0016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00417-012-2108-3","article-title":"Ocular hypertension and glaucoma incidence in patients with scleritis","volume":"251","author":"Heinz","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2021.09.008_bib0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajo.2018.03.027","article-title":"Difluprednate for the treatment of uveitic cystoid macular edema","volume":"191","author":"Schallhorn","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.09.008_bib0018","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2147\/OPTH.S10696","article-title":"Difluprednate ophthalmic emulsion 0.05% (Durezol) administered two times daily for managing ocular inflammation and pain following cataract surgery","volume":"4","author":"Smith","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2021.09.008_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcrs.2008.09.024","article-title":"Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain","volume":"35","author":"Korenfeld","year":"2009","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"10.1016\/j.ajo.2021.09.008_bib0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421004657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421004657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:48:58Z","timestamp":1757598538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421004657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":20,"alternative-id":["S0002939421004657"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.09.008","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Difluprednate for the Treatment of Anterior Scleritis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}